WELCURE DRUGS & PHARMACEUTICAL Share Price

WELCURE DRUGS & PHARMACEUTICAL Share Price

BSE: 524661
|
Trading
|
S Cap
₹ 0.24
+₹0.01 (4.35%)
1D
Last updated 13 Aug, 2026, 15:29 IST

WELCURE DRUGS & PHARMACEUTICAL Share Price Today

As of 14 Aug 2026, WELCURE DRUGS & PHARMACEUTICAL share price is ₹0.24. The stock opened at ₹0.24, compared to its previous close of ₹0.23. During today's trading session, WELCURE DRUGS & PHARMACEUTICAL share price moved in the range of ₹0.23 to ₹0.24, with an average price of ₹0.23 for the day. Looking at its last 52-week, the stock has touched a low of ₹0.22 and a high of ₹1.17.


₹0.23
4.35% up today
₹0.24
1D LOW
1D HIGH

WELCURE DRUGS & PHARMACEUTICAL Returns Calculator


Circuit
L
H
₹0.19
₹0.27
52-week
L
H
₹0.22
₹1.17

About WELCURE DRUGS & PHARMACEUTICAL

WELCURE DRUGS & PHARMACEUTICAL Share Price
ISIN
INE331C01025
Sector Market Cap
₹ 6.21 Cr

Welcure Drugs and Pharmaceuticals Limited is an India-based company. The Company operates in one segment, which is Dealing in medical products.

WELCURE DRUGS & PHARMACEUTICAL Financial Highlights

  • Revenue: WELCURE DRUGS & PHARMACEUTICAL reported revenue of ₹367.00 crore in FY26 vs ₹26.46 crore in FY25. It showed an increase of 1,287.00% on a yearly basis.
  • Operating Profit: WELCURE DRUGS & PHARMACEUTICAL reported an operating loss of ₹5.49 crore in FY26 vs ₹2.78 crore in FY25. It showed a decrease of 297.48% on a year-on-year basis.
  • Net Profit: WELCURE DRUGS & PHARMACEUTICAL reported a net loss of ₹5.49 crore in FY26 vs ₹2.17 crore in FY25. It showed a decrease of 353.00% on a yearly basis.

WELCURE DRUGS & PHARMACEUTICAL Quarterly Result Highlights

  • WELCURE DRUGS & PHARMACEUTICAL reported revenue of ₹0.00 crore in Mar 2026, compared with ₹1.46 crore in Dec 2025, representing a decrease of 100.00% on a quarter-on-quarter (QoQ) basis.
  • WELCURE DRUGS & PHARMACEUTICAL reported an operating loss of ₹49.86 crore in Mar 2026, compared with ₹1.43 crore in Dec 2025, representing a decrease of 3,586.71% on a quarter-on-quarter (QoQ) basis.
  • WELCURE DRUGS & PHARMACEUTICAL reported a loss of ₹49.86 crore in Mar 2026, compared with ₹1.07 crore in Dec 2025, reflecting a decrease of 4,759.81% on a QoQ basis.
  • The earnings per share (EPS) of WELCURE DRUGS & PHARMACEUTICAL stood at ₹0.36 during Mar 2026.
Know more
Promoters
0.00%
FII
0.00%
Other DII
0.00%
Retail and other
100.00%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Jun 20250.00%
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Mkt Cap Cr
6.21

P/E
0.00

P/B
0.29

ROE
0.00%

D/E
0.00

ROCE
0.00%

Div. Yield
0.00%

EPS(TTM)
-0.04
Turnover
3.77

EV/EBITDA
0.00

Net Margin
0.00%

Op. Margin
0.00%

ROA
-20.13%

Quick Ratio
0.00

Curr. Ratio
0.87
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Welcure Drugs has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Welcure Drugs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
ADANI ENTERPRISES4,03,322.0053.684.263.93%0.185.11%574.690.04%0.2893.20
PREMIER ENERGIES LIMITED47,655.8028.4711.0635.05%0.3126.37%42.630.02%0.283.19
Aegis Logistics44,382.2029.677.2314.83%0.1215.38%98.560.70%0.8726.88
Redington26,568.6017.652.6114.67%0.2815.80%67.831.77%4.1015.91
HONASA CONSUMER LIMITED15,254.7076.2110.8014.16%0.0817.48%42.840.64%1.555.86
LLOYDS ENTERPRISES LTD11,839.3041.602.806.84%0.0910.45%34.100.19%0.061.98
MMTC9,667.5021.634.564.72%0.007.79%11.330.00%0.001.41
SG MART LIMITED9,041.7772.765.666.96%0.0110.42%122.330.00%2.937.01
GNG ELECTRONICS LIMITED6,522.0345.808.6117.42%0.2815.97%44.260.00%1.453.50
Arvind Fashions6,011.8931.796.2812.99%0.1018.06%174.180.36%0.260.10

WELCURE DRUGS & PHARMACEUTICAL Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹24.55₹0.00₹0.00₹0.11
Other Income₹1.91₹0.09₹0.24₹0.00
Total Revenue₹26.46₹0.09₹0.24₹0.11
Total Expenses₹23.68₹0.27₹0.14₹0.08
Profit Before Tax₹2.78-₹0.17₹0.10₹0.02
Tax₹0.61₹0.00₹0.00₹0.00
Profit After Tax₹2.17-₹0.17₹0.10₹0.02
EPS - Basic₹0.36-₹0.13₹0.08₹0.02
EPS - Diluted₹0.36-₹0.13₹0.08₹0.02

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹2.78-₹0.17₹0.10₹0.02
Income before WC changes₹2.79-₹0.14₹0.10₹0.02
Change in Assets-₹265.44-₹0.01₹0.00-₹0.01
Change in Liabilities₹40.63₹0.02₹0.01₹0.00
Change in WC-₹224.82₹0.01₹0.01-₹0.01
Cash flow from Operations-₹222.03-₹0.13₹0.11₹0.02
Cash flow from Investing-₹0.06₹0.17₹0.00₹0.00
Cash flow from Financing₹222.20-₹0.02-₹0.17₹0.00
Total Cash Flow₹0.11₹0.02-₹0.06₹0.02
Cash (Start of the year)₹0.02₹0.00₹0.07₹0.05
Cash (End of the year)₹0.13₹0.02₹0.00₹0.07

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹84.84₹1.34₹1.52₹0.03
Current Assets₹182.14₹0.03₹0.01₹0.07
Total Assets₹266.98₹1.37₹1.53₹0.10
Current Liabilities₹41.27₹0.03₹0.01₹0.00
Net Current Asset₹140.87₹0.00-₹0.01₹0.06
Non-Current Liabilities₹123.20₹0.00₹0.00₹0.00
Equity Capital₹102.51₹1.34₹1.52₹0.09
Total Equity & Liabilities₹266.98₹1.37₹1.53₹0.10
* All values are in INR Crore
Qty
Bid
3295658
0.23
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 3295658
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
4
Bullish
2
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
38.62
Neutral

ATR (14)
0.02
Neutral

STOCH(9,6)
0
Bullish

STOCH RSI (14)
0
Bullish

ADX(9)
40.07
Bearish

UO(9)
42.94
Neutral

ROC(12)
-4.17
Bearish

WillR(14)
-66.67
Neutral
Period
Simple value
Exponential vaue

5D
0.24
0.24

10D
0.24
0.24

20D
0.24
0.24

50D
0.25
0.26

100D
0.27
0.28
Volume trend — traded volume by day
13 Aug30L
12 Aug24L
11 Aug37L
10 Aug60L
7 Aug26L
Average35L
Compare against other stocks
WELCURE DRUGS & PHARMACEUTICAL Share Price
WELCURE DRUGS & PHARMACEUTICAL
Trading
Add Stock
Add Another

WELCURE DRUGS & PHARMACEUTICAL Share Price FAQs